Intratumoral Escherichia Correlates with Survival in Single-Agent ICI for NSCLC
The following is a summary of “Intratumoral Escherichia Is Associated With Improved Survival to Single-Agent Immune Checkpoint Inhibition in Patients With Advanced Non–Small-Cell Lung Cancer,” published in the July 2024 issue of Oncology by Elkrief et al. The...